Respiratory Infections News

Data from Los Angeles County during the omicron surge showed that the COVID-19 hospitalization rate was 23 times higher among people who were unvaccinated compared with people who had received a COVID-19 vaccine series and booster.

A phase 2 trial will evaluate if temporarily reducing the immunosuppressive medication of transplant recipients in the days before and after they receive an additional dose of COVID-19 vaccine increases their immune response to the vaccine.

Pfizer and BioNTech are expected to ask the FDA to authorize a two-dose regimen of their COVID-19 vaccine for emergency use in children younger than age 5 years, according to multiple reports.

Novavax on Monday announced that it has submitted an emergency use authorization request to the FDA for its protein-based COVID-19 vaccine for individuals aged 18 years or older.

The FDA on Monday approved Moderna’s COVID-19 vaccine, making it the second fully approved COVID-19 vaccine in the United States.

People previously infected with SARS-CoV-2 are substantially protected against COVID-19 for several months, even in the absence of vaccination, a study found.

The AAP urged that school districts prioritize in-person learning in updates to their interim pandemic guidance published today.

Researchers identified four factors that may anticipate if a patient will develop long COVID.

Adolescents who were homeschooled during a COVID-19 lockdown slept longer on school days and drank less alcohol and caffeine than before the pandemic, according to a cross-sectional online survey of nearly 9,000 students in Switzerland.

Moderna on Wednesday announced the start of a phase 2 study of an omicron-specific COVID-19 booster shot.